Landscape Capital Management’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,045
Closed -$346 768
2025
Q4
$346 Hold
32,045
﹤0.01% 696
2025
Q3
$843 Hold
32,045
﹤0.01% 602
2025
Q2
$923 Hold
32,045
﹤0.01% 635
2025
Q1
$346 Hold
32,045
﹤0.01% 615
2024
Q4
$704 Hold
32,045
﹤0.01% 698
2024
Q3
$481 Hold
32,045
﹤0.01% 643
2024
Q2
$961 Hold
32,045
﹤0.01% 682
2024
Q1
$817 Hold
32,045
﹤0.01% 711
2023
Q4
$993 Hold
32,045
﹤0.01% 808
2023
Q3
$724 Hold
32,045
﹤0.01% 495
2023
Q2
$2.3K Hold
32,045
﹤0.01% 502
2023
Q1
$4.72K Hold
32,045
﹤0.01% 582
2022
Q4
$3.2K Hold
32,045
﹤0.01% 805
2022
Q3
$1K Sell
32,045
-2,712
-8% -$130 ﹤0.01% 942
2022
Q2
$1K Buy
+34,757
New +$2.61K ﹤0.01% 943

Other funds holding COEPW

Landscape Capital Management's COEPW Position: Q1 2026 in Review

Landscape Capital Management sold out of Coeptis Therapeutics Warrants (COEPW) in Q1 2026, closing a stake of 32,045 shares — an estimated $346 sold.

Landscape Capital Management first reported a position in COEPW in Q2 2022 and held it in 15 quarters. The position peaked at $4.72K in Q1 2023. 10 funds tracked by Wall St. Rank hold COEPW as of Q1 2026.

  • Landscape Capital Management reported no remaining Coeptis Therapeutics Warrants position as of Q1 2026 after selling out during the quarter.
  • Landscape Capital Management sold 32,045 Coeptis Therapeutics Warrants shares in Q1 2026, an estimated $346.
  • Landscape Capital Management first reported a position in Coeptis Therapeutics Warrants in Q2 2022 and held it in 15 quarters.
  • Landscape Capital Management's Coeptis Therapeutics Warrants position peaked at $4.72K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.